Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer

Gynecologic Oncology

Volumn 68, Issue 3, 1998, Pages 247-252

  Fujiwaki, Ritsuto ^a   Hata, Kohkichi ^a   Iida, Kohji ^a   Koike, Mikio ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; THYMIDINE PHOSPHORYLASE; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENOPAUSE; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 0032031005     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4929     Document Type: Article

References (35)

1. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med. 285:1994;1182-1186.
2. Folkman J. Clinical application of research on angiogenesis. N Engl J Med. 333:1995;1757-1763.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:1995;27-31.
4. Weidner N, Semple J P, Welch W R, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
5. Weidner N, Carrol P R, Flax J, Blumenfield W, Folkman J. Tumor angiogenesis correlated with metastasis in invasive prostate carcinoma. Am J Pathol. 143:1993;401-409.
6. Abulafia O, Triest W, Sherer D M, Hansen C C, Ghezzi F. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol. 86:1995;479-485.
7. Morgan K G, Wilkinson N, Buckley H. Angiogenesis is normal, hyperplastic, and neoplastic endometrium. J Pathol. 179:1996;317-320.
8. Kirschner C V, Alanis-Amezua J M, Martin V G, Luna N, Morgan E, Yang J J, Yordan E L. Angiogenesis factor in endometrial carcinoma: A new prognostic indicator. Am J Obstet Gynecol. 174:1996;1879-1884.
9. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin C H. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem. 262:1987;4098-4103.
10. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Uskui K, Takaku F, Risau W, Heldin C H. Identification of angiogenetic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 38:1989;557-562.
11. Moghaddam A, Bicknell R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry. 31:1992;12141-12146.
12. Moghaddam A, Zhang H T, Fan T P, Hu D E, Lees V C, Turley H, Fox S B, Gatter K C, Harris A L, Bicknell R. Thymidine phosphorylase in angiogenic and promotes tumor growth. Proc Natl Acad USA. 92:1995;998-1002.
13. Haraguchi M, Kazutaka M, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S. Angiogenic activity of enzymes. Nature. 368:1994;198.
14. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer. 64:1995;79-82.
15. Fox S B, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse R M, Bicknell R, Gatter K C, Harris A L. The antigenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer. 73:1996;275-280.
16. Maeda K, Chung Y-S, Ogawa S, Takatsuka S, Kang S M, Ogawa M, Sawada T, Onoda N, Kato Y, Sowa M. Thymdine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer. 73:1996;884-888.
17. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T, Aikou T. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res. 87:1996;288-295.
18. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F, Aikou T. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst. 88:1996;1110-1117.
19. Takahashi Y, Bucana C D, Liu W, Yamada J, Kitadai Y, Cleary K R, Ellis L M. Platelet-delivered endothelial cell growth factor in human colon cancer angiogenesis: Role of infiltrating cells. J Natl Cancer Inst. 88:1996;1146-1151.
20. O'Brien T S, Fox S B, Dickison A J, Turley H, Westwood M, Moghaddam A, Gatter K C, Bicknell R, Harris A L. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res. 56:1994;4799-4804.
21. Koukourakis M I, Giatromanolaki A, O'Byrne K J, Comley M, Whitehouse R M, Talbot D C, Gatter K C, Harris A L. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer. 75:1997;477-481.
22. Giatromanolaki A, Koukourakis M I, Comley M, Kaklamanis L, Turley H, O'Byrne K, Harris A L, Gatter K C. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol. 181:1997;196-199.
23. Hata K, Hata T, Collins W P. Association between the concentration of thymidine phosphorylase and ultrasound derived indices of blood flow in ovarian mass. Cancer. 80:1997;1079-1084.
24. Int J Gynaecol Obstet. 28:1989;190.
25. Poulsen, H, Taylor, C, W, Sobin, L, H, Histological typing of female genital tract tumors, International histologic classification of tumors, Geneva, World Health Organization, 13, 63, 73, 1975.
26. Burke T W, Gershenson D M, Morris M, Stringer C A, Levenback C, Torotolero-Luna G, Backer V V. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 55:1994;47-50.
27. Torrisi J R, Barnes W A, Popescu G, Whitfield G, Bater J, Lewwandowski G, Delgado G. Postoperative adjuvant external-beam radiotherapy in surgical stage I endometrial carcinoma. Cancer. 64:1989;1414-1417.
28. Lin H H, Chen C D, Chen C K, Chen C L, Chow S N, Huang S C. Is total abdominal hysterectomy with bilateral salpingo-oophorectomy adequate for new FIGO stage I endometrial carcinoma. Br J Obstet Gynaecol. 102:1995;148-152.
29. Nishida M, Hino A, Mori K, Matsumoto T, Tanaka Y, Ishitsuka H. Cloning of hybridomas producing anti-human thymidine phosphorylase (dThdPase) and establishment ELISA for measuring dThdPase. J Jpn Soc Cancer Ther. 29:1994;1192.
30. Guidi A J, Abu-Jawdeh G, Tognazzi K, Dovorak H F, Brown L F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer. 78:1996;454-460.
31. Gold L I, Saxena B, Mittal K R, Marmor M, Goswami S, Nactigal L, Korc M, Demopoulos R I. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: Evidence for paracrine and autocrine action. Cancer Res. 54:1994;2347-2358.
32. Santini D, Ceccarelli C, Martinelli G N, Leone O, Marabini A, Orlandic C, Mancini A M. Immunocytochemical study of epidermal growth factor receptor, transforming growth factor alpha, and squamous differentiation in human endometrial carcinoma. Hum Pathol. 25:1994;1319-1323.
33. Reinartz J J, George E, Lindgern B R, Niehans G A. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival. Hum Pathol. 25:1994;1075-1083.
34. Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol. 64:1997;411-417.
35. Lurain J R, Rice B L, Rademaker A W, Poggensee L E, Schink J C, Miller D S. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol. 63:1991;63-69.